Cisplatin Chemotherapy and Cochlear Damage: Otoprotective and Chemosensitization Properties of Polyphenols

耳毒性 顺铂 药理学 姜黄素 信号转导 氧化应激 活性氧 医学 癌症研究 化疗 化学 生物化学 内科学
作者
Anna Rita Fetoni,Fabiola Paciello,Diana Troiani
出处
期刊:Antioxidants & Redox Signaling [Mary Ann Liebert]
卷期号:36 (16-18): 1229-1245 被引量:24
标识
DOI:10.1089/ars.2021.0183
摘要

Significance: Cisplatin is an important component of treatment regimens for different cancers. Notwithstanding that therapeutic success often results from partial efficacy or stabilizing the disease, chemotherapy failure is driven by resistance to drug treatment and occurrence of side effects, such as progressive irreversible ototoxicity. Cisplatin's side effects, including ototoxicity, are often dose limiting. Recent Advances: Cisplatin ototoxicity results from several mechanisms, including redox imbalance caused by reactive oxygen species production and lipid peroxidation, activation of inflammation, and p53 and its downstream pathways that culminate in apoptosis. Considerable efforts in research have targeted development of molecular interventions that can be concurrently administered with cisplatin or other chemotherapies to reduce side effect toxicities while preserving or enhancing the antineoplastic effects. Evidence from studies has indicated some polyphenols, such as curcumin, can help to regulate redox signaling and inflammatory effects. Furthermore, polyphenols can exert opposing effects in different types of tissues, that is, normal cells undergoing stressful conditions versus cancer cells. Critical Issues: This review article summarizes evidence of curcumin antioxidant effect against cisplatin-induced ototoxicity that is converted to a pro-oxidant activity in cisplatin-treated cancer cells, thus providing an ideal chemosensitivity combined with otoprotection. Polyphenols can modulate the adaptive responses to stress in the cisplatin-exposed cochlea. These adaptive effects can result from the interaction/cross talk between the cell's defenses, inflammatory molecules, and the key signaling molecules of signal transducers and activators of transcription 3 (STAT-3), nuclear factor κ-B (NF-κB), p53, and nuclear factor erythroid 2-related factor 2 (Nrf-2). Future Directions: We provide molecular evidence for alternative strategies for chemotherapy with cisplatin addressing the otoprotection and chemosensitization properties of polyphenols. Antioxid. Redox Signal. 36, 1229-1245.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
量子星尘发布了新的文献求助10
2秒前
在水一方应助铜锣烧采纳,获得10
2秒前
桐桐应助U123456采纳,获得30
4秒前
zhaopenghui发布了新的文献求助10
4秒前
5秒前
玩命的黑裤应助舒适访彤采纳,获得10
5秒前
清爽饼干完成签到,获得积分10
6秒前
6秒前
6秒前
善学以致用应助smile采纳,获得10
8秒前
HAO完成签到,获得积分10
8秒前
大模型应助蓝天采纳,获得10
8秒前
晴朗的蓝完成签到,获得积分10
8秒前
9秒前
9秒前
sdshi发布了新的文献求助10
10秒前
Smallriver发布了新的文献求助10
11秒前
11秒前
爆米花应助Lxy_zb采纳,获得10
11秒前
榴莲姑娘发布了新的文献求助30
12秒前
13秒前
可舒发布了新的文献求助10
13秒前
希望天下0贩的0应助Jun采纳,获得10
14秒前
16秒前
GUO发布了新的文献求助10
16秒前
serenity完成签到 ,获得积分10
16秒前
hahaya完成签到,获得积分20
16秒前
三三完成签到,获得积分10
17秒前
U123456发布了新的文献求助30
19秒前
科研通AI6应助师震铎采纳,获得10
19秒前
20秒前
量子星尘发布了新的文献求助10
21秒前
核桃应助满天星采纳,获得30
21秒前
灵巧半莲完成签到,获得积分10
22秒前
谦让R发布了新的文献求助10
23秒前
23秒前
ljc完成签到 ,获得积分10
23秒前
Melody完成签到,获得积分10
25秒前
yy完成签到,获得积分10
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1601
以液相層析串聯質譜法分析糖漿產品中活性雙羰基化合物 / 吳瑋元[撰] = Analysis of reactive dicarbonyl species in syrup products by LC-MS/MS / Wei-Yuan Wu 1000
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 800
Biology of the Reptilia. Volume 21. Morphology I. The Skull and Appendicular Locomotor Apparatus of Lepidosauria 600
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 500
Pediatric Nutrition 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5553450
求助须知:如何正确求助?哪些是违规求助? 4637983
关于积分的说明 14651924
捐赠科研通 4579900
什么是DOI,文献DOI怎么找? 2511951
邀请新用户注册赠送积分活动 1486817
关于科研通互助平台的介绍 1457747